Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1
Posted Date:
Jan 14, 2025
Due Date:
Jan 15, 2025
Awarded Date:
Jun 25, 2024
| SetAside Type | ||
| Total Small Business Set-Aside (FAR 19.5) | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N93024C00019 | Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1 | |
| Synopsis | ||
|
Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1 .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | AWARD Notice | |
| SetAside Type | ||
| Total Small Business Set-Aside (FAR 19.5) | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N93024C00019 | Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1 | |
| Synopsis | ||
|
Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1 .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | AWARD Notice | |
